Centre for Optimisation of Medicines, Pharmacy, School of Medicine and Pharmacology, University of Western Australia, Crawley, Western Australia, Australia.
BMJ Open. 2013 Aug 17;3(8):e003338. doi: 10.1136/bmjopen-2013-003338.
To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention called Emergency Contraception Mediated Pharmacy Access to Chlamydia Testing (ECOMPACT).
Selective, opportunistic and cross-sectional study targeting asymptomatic women requesting emergency contraception (EC).
20 community pharmacies in the Perth metropolitan region, Australia.
ECOMAPCT was developed through literature review and stakeholder consensus. Pharmacists were trained to offer ECOMPACT after the EC consultation. Women with signs and symptoms of sexually transmitted infections (STI) were referred to a physician for a full sexual health check. Asymptomatic women were offered a free ECOMPACT testing kit. The women self-collected a low-vaginal swab and returned their pathological specimen to designated drop-off sites. A pathology service analysed the specimens and sent the results to a sexual health physician. The effectiveness of ECOMPACT was determined by the uptake of the intervention and how well the target population was reached. An effective screening rate was calculated. Qualitative analysis was undertaken to understand acceptability issues from the perspective of the consumer and the pharmacists.
Of the 769 EC consultations in a 6-month period, 569 (78%) women were given information on chlamydia screening. All 247 (41%) agreed to participate. 81 (33%) of these women were ineligible. They were either symptomatic (n=33; 41%), or were under 18 years of age (n=48; 59%). Pharmacists successfully requested 166 (67%) pathology tests, of which 46 (28%) were returned to a pathology drop-off site. All tested negative for Chlamydia trachomatis. The effective screening rate was 6%. Consumers and pharmacists considered ECOMPACT to be highly convenient and the time taken to offer a chlamydia test along with an EC consultation as highly appropriate.
ECOMPACT was found to be simple, effective and acceptable. Given the opportunity, adequate training and support, community pharmacists in Australia were capable of requesting direct-to-consumer chlamydia tests.
开发并评估一种名为“紧急避孕介导的药店获取衣原体检测（ECOMPACT）”的基于药店的衣原体筛查干预措施的有效性和可接受性。
针对要求紧急避孕（EC）的无症状女性，进行有选择性、机会性和横断面研究。
澳大利亚珀斯大都市区的 20 家社区药店。
通过文献回顾和利益相关者共识制定 ECOMAPCT。培训药剂师在 EC 咨询后提供 ECOMPACT。有性传播感染（STI）症状和体征的女性被转介给医生进行全面的性健康检查。无症状女性则获得免费的 ECOMPACT 检测试剂盒。女性自行采集阴道下段拭子并将其病理标本交至指定的交回点。病理服务机构对标本进行分析，并将结果发送给性健康医生。通过干预措施的接受程度和目标人群的覆盖情况来确定 ECOMPACT 的有效性。计算有效的筛查率。从消费者和药剂师的角度进行定性分析，以了解可接受性问题。
在 6 个月的时间内，769 次 EC 咨询中有 569 名（78%）女性获得了衣原体筛查信息。所有 247 名（41%）同意参与。其中 81 名（33%）不符合条件。她们要么有症状（n=33；41%），要么年龄在 18 岁以下（n=48；59%）。药剂师成功要求进行 166 次（67%）病理检查，其中 46 次（28%）被交回病理交回点。所有检测结果均为沙眼衣原体阴性。有效筛查率为 6%。消费者和药剂师认为 ECOMPACT 非常方便，在 EC 咨询期间提供衣原体检测的时间也非常合适。
ECOMPACT 被证明简单、有效且可接受。在获得机会、充分培训和支持的情况下，澳大利亚的社区药剂师能够要求消费者直接进行衣原体检测。
